Join industry leaders to explore, discuss, and analyze the latest trends and controversies surrounding clinical pathways, oncology treatment, and the ever-evolving business of cancer care.
Below are the topics we will be covering at this fall's event. Stay tuned for the full 2025 agenda to be released soon!
Integrating Cutting-Edge Therapies in Outpatient and Community Care
Discover how emerging treatments—from bispecific antibodies and CAR T-cell therapy to radiopharmaceuticals and theranostics—are implemented in outpatient and community settings. This topic highlights key infrastructure needs, operational strategies, and real-world insights for adapting to the evolving therapeutic landscape.
JCP Clinical Pathways Category: Infrastructure & Innovation
Real-World Impact of AI in Oncology Care and Operations
This topic explores AI's transformative role in clinical documentation and operational support, highlighting practical implementations that enhance efficiency, democratize information, and support better decision-making across the oncology care continuum. Attendees will gain insights into how tools like DeepScribe are already reshaping real-world workflows, from patient encounters to administrative processes.
JCP Clinical Pathways Category: Infrastructure & Innovation
The Evolution of Pharmacist Leadership
Explore pharmacists' expanding leadership role in implementing integration pathways across oncology care networks. Attendees will gain insights into the challenges, strategies, and impact of pharmacist-led initiatives in advancing coordinated, value-driven care.
JCP Clinical Pathways Category: Treatment
Real-World Evidence in Oncology Innovation
Examine how real-world evidence (RWE) is integrated into oncology clinical pathways to inform treatment decisions and optimize patient outcomes. We will explore RWE's critical role in advancing value-based care and aligning innovations with practical, evidence-driven strategies.
JCP Clinical Pathways Category: Outcome Measurements
State of Healthcare: What Cancer Stakeholders Need to Know
Receive a high-level overview of the current healthcare landscape, focusing on the key trends, policies, and innovations shaping cancer care. Plus, gain insights into the evolving priorities of payers, providers, policymakers, and patients—and what these shifts mean for oncology stakeholders today.
JCP Clinical Pathways Category: Infrastructure & Innovation
Predictable Cost of Care Working Group Update
The Predictable Cost of Care (PCOC) Working Group is a multi-stakeholder panel developing new industry standards for economic models, including a wider range of treatment-related costs to guide pathway decisions. This session will provide an update on the work PCOC is doing, including exciting findings and patient metrics collected during Phase 2 of their working group.
JCP Clinical Pathways Category: Outcome Measurements
Patient Support and Extended Cross-Continuum Care Management
This session explores strategies to extend patient support and care management beyond the clinic, focusing on coordinated, whole-person care. Attendees will learn how health systems can create more connected, patient-centered experiences that improve outcomes across the cancer care journey.
JCP Clinical Pathways Category: Infrastructure & Innovation
Integrating Comprehensive Care Needs into Clinical Pathways
Explore integrating social, financial, and logistical needs into clinical pathways, focusing on the importance of developing care models that incorporate these elements into existing workflows. This session aims to provide a foundational understanding of how comprehensive care needs can be effectively integrated into clinical practice.
JCP Clinical Pathways Category: Business
